Granulovacuolar degeneration (GVD) bodies of Alzheimer's disease (AD) resemble late-stage autophagic organelles

被引:92
|
作者
Funk, K. E. [1 ]
Mrak, R. E. [2 ]
Kuret, J. [1 ]
机构
[1] Ohio State Univ, Ctr Mol Neurobiol, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA
[2] Univ Toledo, Dept Pathol, Coll Med, Toledo, OH 43606 USA
关键词
Alzheimer's disease; autophagy; endocytosis; granulovacuolar degeneration; lysosome; MULTIVESICULAR BODY BIOGENESIS; NEUROFIBRILLARY TANGLES; ESCRT-III; ENDOCYTIC TRAFFICKING; HIPPOCAMPAL CORTEX; DEMENTED PATIENTS; ACID-HYDROLASES; TAU; PROTEIN; NEURONS;
D O I
10.1111/j.1365-2990.2010.01135.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aims: Granulovacuolar degeneration involves the accumulation of large, double membrane-bound bodies within certain neurones during the course of Alzheimer's disease (AD) and other adult-onset dementias. Because of the two-layer membrane morphology, it has been proposed that the bodies are related to autophagic organelles. The aim of this study was to test this hypothesis, and determine the approximate stage at which the pathway stalls in AD. Methods: Spatial colocalization of autophagic and endocytic markers with casein kinase 1 delta, a marker for granulovacuolar degeneration (GVD) bodies, was evaluated in hippocampal sections prepared from post mortem Braak stage IV and V AD cases using double-label confocal fluorescence microscopy. Results: GVD bodies colocalized weakly with early-stage autophagy markers LC3 and p62, but strongly with late-stage marker lysosome-associated membrane protein 1 (LAMP1), which decorated their surrounding membranes. GVD bodies also colocalized strongly with charged multivesicular body protein 2B (CHMP2B), which colocalized with the core granule, but less strongly with lysosomal marker cathepsin D. Conclusions: The resultant immunohistochemical signature suggests that granulovacuolar degeneration bodies (GVBs) do contain late-stage autophagic markers, and accumulate at the nexus of autophagic and endocytic pathways. The data further suggest that failure to complete autolysosome formation may be an important correlate of GVB accumulation.
引用
收藏
页码:295 / 306
页数:12
相关论文
共 50 条
  • [21] Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer's disease but not Lewy body dementias
    Chai, Yuek Ling
    Lee, Jasinda H. H.
    Chong, Joyce R. R.
    Ballard, Clive
    Francis, Paul T.
    Kennedy, Brian K.
    Arumugam, Thiruma V.
    Chen, Christopher P. P.
    Aarsland, Dag
    Lai, Mitchell K. P.
    JOURNAL OF NEUROINFLAMMATION, 2023, 20 (01)
  • [22] Emerging Alzheimer's disease treatment paradigms: A late-stage clinical trial review
    Hlavka, Jakub P.
    Kinoshita, Andrew T.
    Jeyasingh, Divya
    Huang, Cheng
    Mirsafian, Leila
    Jacobson, Mireille
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2024, 10 (04)
  • [23] Expression of inflammatory genes in the primary visual cortex of late-stage Alzheimer's disease
    Cui, Jian-Guo
    Hill, James M.
    Zhao, Yuhai
    Lukiw, Walter J.
    NEUROREPORT, 2007, 18 (02) : 115 - 119
  • [24] "To Treat or not To Treat": Informing the Decision for Disease-Modifying Therapy in Late-Stage Alzheimer's Disease
    Watt, Andrew D.
    Jenkins, Nicole L.
    McColl, Gawain
    Collins, Steven
    Desmond, Patricia M.
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 68 (04) : 1321 - 1323
  • [25] LATE-NC aggravates GVD-mediated necroptosis in Alzheimer’s disease
    Marta J. Koper
    Sandra O. Tomé
    Klara Gawor
    Annelies Belet
    Evelien Van Schoor
    Jolien Schaeverbeke
    Rik Vandenberghe
    Mathieu Vandenbulcke
    Estifanos Ghebremedhin
    Markus Otto
    Christine A. F. von Arnim
    Sriram Balusu
    Matthew B. Blaschko
    Bart De Strooper
    Dietmar Rudolf Thal
    Acta Neuropathologica Communications, 10
  • [26] Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD
    Tramutola, Antonella
    Triplett, Judy C.
    Di Domenico, Fabio
    Niedowicz, Dana M.
    Murphy, Michael P.
    Coccia, Raffaella
    Perluigi, Marzia
    Butterfield, D. Allan
    JOURNAL OF NEUROCHEMISTRY, 2015, 133 (05) : 739 - 749
  • [27] Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer’s disease but not Lewy body dementias
    Yuek Ling Chai
    Jasinda H. Lee
    Joyce R. Chong
    Clive Ballard
    Paul T. Francis
    Brian K. Kennedy
    Thiruma V. Arumugam
    Christopher P. Chen
    Dag Aarsland
    Mitchell K. P. Lai
    Journal of Neuroinflammation, 20
  • [28] Co-occurrence of mixed proteinopathies in late-stage Huntington's disease
    St-Amour, Isabelle
    Turgeon, Andreanne
    Goupil, Claudia
    Planel, Emmanuel
    Hebert, Sebastien S.
    ACTA NEUROPATHOLOGICA, 2018, 135 (02) : 249 - 265
  • [29] Profile of cognitive impairment in late-stage Parkinson's disease
    Sousa, Catarina Severiano E.
    Fabbri, Margherita
    Godinho, Catarina
    Simoes, Rita Moiron
    Chendo, Ines
    Coelho, Miguel
    Martins, Isabel Pavao
    Ferreira, Joaquim J.
    BRAIN AND BEHAVIOR, 2022, 12 (04):
  • [30] An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration
    Walton, J. R.
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2007, 101 (09) : 1275 - 1284